PVRTIGIT

Ester Lozano1,2,3, Mari-Pau Mena2,3, Glòria Garrabou4,5

  • 1Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona (UB), Barcelona, Spain.

概括

在多发性骨髓瘤中,骨髓巨细胞上的脊髓病毒受体 (PVR) 表达抑制T细胞反应,导致对TIGIT阻塞疗法的耐药性.